Heart rate dependency of cardiac performance in heart failure patients treated with metoprolol

European Heart Journal

Volumn 20, Issue 8, 1999, Pages 575-583

  Andersson, B ^a   Stromblad S O ^a   Lomsky, M ^b   Waagstein, F ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adrenergic beta blocker; Diastolic function; Dilated cardiomyopathy; Force frequency; Heart rate; Pacing

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; METOPROLOL; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLE; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HEART DILATATION; HEART FAILURE; HEART FUNCTION; HEART MUSCLE CONTRACTILE FORCE; HEART PERFORMANCE; HEART RATE; HEART VENTRICLE EJECTION TIME; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCINTIANGIOGRAPHY; SYSTOLE;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; CARDIAC OUTPUT; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HEART RATE; HEMODYNAMIC PROCESSES; HUMANS; MALE; METOPROLOL; MIDDLE AGED; SURVIVAL RATE; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 0344628879     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1998.1315     Document Type: Article

References (31)

1. Kjekshus J. Heart rate reduction - a mechanism of benefit? Eur Heart J. 8:1987;115-122.
2. Colucci WS, Ribeiro JP, Rocco MB. Impaired chronotropic response to exercise in patients with congestive heart failure. Circulation. 80:1989;314-323.
3. Sugiura T, Iwasaka T, Hasegawa T, Takahashi N, Matsutani M, Inada M. Effect of propranolol on diastolic time during exercise. J Cardiovasc Pharmacol. 15:1990;371-376.
4. Boudoulas H, Rittgers SE, Lewis RP, Leier CV, Weissler AM. Changes in diastolic time with various pharmacologic agents. Circulation. 60:1979;164-169.
5. Schang SJ, Pepine CJ. Effects of propranolol on coronary hemodynamic and metabolic responses to tachycardia stress in patients with and without coronary disease. Cathet Cardiovasc Diagn. 3:1977;47-57.
6. Buck JD, Hardman HF, Warltier DC, Gross GJ. Changes in ischemic blood flow distribution and dynamic severity of a coronary stenosis induced by beta blockade in the canine heart. Circulation. 64:1981;708-715.
7. Andersson B, Lomsky M, Waagstein F. The link between acute haemodynamic adrenergic beta-blockade and long-term effects in patients with heart failure. Eur Heart J. 14:1993;1375-1385.
8. Andersson B, Hamm C, Persson S. Improved exercise hemodynamic status in dilated cardiomyopathy after beta-adrenergic blockade treatment. J Am Coll Cardiol. 23:1994;1397-1404.
9. Eichhorn EJ, Heesch CM, Barnett JH. Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol. 24:1994;1310-1320.
10. Mulieri LA, Hasenfuss G, Leavitt B, Allen PD, Alpert NR. Altered myocardial force-frequency relation in human heart failure. Circulation. 85:1992;1743-1750.
11. Hasenfuss G, Holubarsch C, Hermann H-P, Astheimer K, Pieske B, Just H. Influence of the force-frequency relationship on haemodynamics and left ventricular function in patients with non-failing hearts and in patients with dilated cardiomyopathy. Eur Heart J. 15:1994;164-170.
12. Andersson B, Caidahl K, Di Lenarda A. Changes in early and late diastolic filling patterns induced by long-term adrenergic beta-blockade in patients with idiopathic dilated cardiomyopathy. Circulation. 94:1996;673-682.
13. Waagstein F, Bristow MR, Swedberg K. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet. 342:1993;1441-1446.
14. Massardo T, Gal RA, Grenier RP, Schmidt DH, Port SC. Left ventricular volume calculation using a count-based ratio method applied to multigated radionuclide angiography. J Nucl Med. 31:1990;450-456.
15. Nickel O, Schad N, Andrews EJ, Fleming JW, Mello M. Scintigraphic measurement of left-ventricular volumes from the count-density distribution. J Nucl Med. 23:1982;404-410.
16. Quaife RA, Gilbert EM, Christian PE. Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy. Am J Cardiol. 78:1996;779-784.
17. Lavine SJ, Krishnaswami V, Shreiner DP, Amidi M. Left ventricular diastolic filling in patients with left ventricular dysfunction. Int J Cardiol. 8:1985;423-436.
18. Ohno M, Cheng C-P, Little WC. Mechanism of altered patterns of left ventricular filling during the development of congestive heart failure. Circulation. 89:1994;2241-2250.
19. Morgan JP, Erny RE, Allen PD, Grossman W, Gwathmey JK. Abnormal intracellular calcium handling, a major cause of systolic and diastolic dysfunction in ventricular myocardium from patients with heart failure. Circulation. 81:1990;III-21-III-23.
20. Gwathmey JK, Slawsky MT, Hajjar RJ, Briggs GM, Morgan JP. Role of intracellular calcium handling in force-interval relationships of human ventricular myocardium. J Clin Invest. 85:1990;1599-1613.
21. Glass MG, Reiss I, Cory R, O'Brien PJ, Gwathmey JK. Reversal of the negative treppe with β-blockers: role of sarcoplasmic reticulum function and myocardial energetics. Circulation. 88:1993;I-526.
22. Buckley NM, Penefsky ZJ, Litwak RS. Comparative force-frequency relationships in human and other mammalian ventricular myocardium. Pflugers Arch. 332:1972;259-270.
23. Feldman MD, Alderman JD, Aroesty JM. Depression of systolic and diastolic myocardial reserve during atrial pacing tachycardia in patients with dilated cardiomyopathy. J Clin Invest. 82:1988;1661-1669.
24. Heilbrunn SM, Shah P, Bristow Mr, Valantine HA, Ginsburg R, Fowler MB. Increased β-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy. Circulation. 79:1989;483-490.
25. Ryu KH, Tanaka N, Dalton N. Force-frequency relations in the failing rabbit heart and responses to adren-ergic stimulation. Cardiac Failure. 3:1997;27-39.
26. Waagstein F, Caidahl K, Wallentin I, Bergh C-H, Hjalmarson Å. Long-term β-blockade in dilated cardiomyopathy. Effects of short-and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol. Circulation. 80:1989;551-563.
27. Böhm M, Deutsch HJ, Hartmann D, Rosee KL, Stablein A. Improvement of postreceptor events by metoprolol treatment in patients with chronic heart failure. J Am Coll Cardiol. 30:1997;992-996.
28. Andersson B, Blomström-Lundqvist C, Hedner T, Waagstein F. Exercise hemodynamics and myocardial metabolism during long-term beta-adrenergic blockade in severe heart failure. J Am Coll Cardiol. 18:1991;1059-1066.
29. Lancet. 349:1997;375-380.
30. Packer M, Bristow MR, Cohn JN. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 334:1996;1349-1355.
31. Waagstein F. Metoprolol in addition to ACE-inhibitors causes regression of left ventricular dilatation and increase exercise ejection fraction in ischemic cardiomyopathy. J Am Coll Cardiol. 29:1997;206A.